DRAM1 (DNA damage-regulated autophagy modulator protein 1) is a lysosomal multi-pass membrane protein with six transmembrane segments, primarily localized to LAMP1-positive lysosomes with its C-terminus facing the cytosol. It is a canonical p53-induced autophagy modulator that plays central roles in: (1) promoting autophagosome-lysosome fusion via stabilization of lysosomal VAMP8 by blocking CHIP-mediated ubiquitination, thereby enabling STX17-SNAP29-VAMP8 SNARE complex assembly; (2) regulating ER-lysosome membrane contact sites through interaction with STIM1, affecting calcium homeostasis and ER-phagy; (3) enhancing lysosomal acidification and protease activation; and (4) promoting xenophagy (antimicrobial autophagy) in host defense against intracellular pathogens such as mycobacteria. DRAM1 is transcriptionally activated by p53 and p73, and is down-regulated in tumor cells by methylation-dependent transcriptional silencing. While DRAM1 is best characterized as a positive regulator of autophagy and p53-mediated apoptosis, its precise enzymatic function remains unclear; it appears to act primarily as an adapter/scaffold protein facilitating autophagy machinery assembly and organelle contact site formation.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005764
lysosome
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: DRAM1 is a well-established lysosomal membrane protein. The IBA annotation based on phylogenetic analysis is strongly supported by multiple experimental studies showing DRAM1 localization to LAMP1-positive lysosomes (Wang et al., 2024 PNAS; Crighton et al., 2006 Cell PMID:16839881). UniProt also annotates DRAM1 to the lysosomal membrane based on experimental evidence.
Reason: Lysosomal localization is a core, well-documented feature of DRAM1. The protein contains 6 transmembrane segments and resides primarily on lysosomes with partial localization to late endosomes and autophagosomes. This is supported by the original discovery paper (PMID:16839881) and recent mechanistic studies.
Supporting Evidence:
PMID:16839881
Here we describe DRAM (damage-regulated autophagy modulator), a p53 target gene encoding a lysosomal protein that induces macroautophagy
file:human/DRAM1/DRAM1-deep-research-falcon.md
DRAM1 is a conserved, multi-pass lysosomal membrane protein (six transmembrane segments) whose C-terminus faces the cytosol. It resides primarily on lysosomes with partial localization to late endosomes and autophagosomes.
|
|
GO:0010506
regulation of autophagy
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: DRAM1 is a canonical autophagy modulator, as indicated by its full name "DNA damage-regulated autophagy modulator protein 1". Multiple mechanistic studies confirm DRAM1 regulates autophagy at multiple levels including autophagosome-lysosome fusion (via VAMP8 stabilization) and ER-phagy (via STIM1 interaction).
Reason: Regulation of autophagy is the primary, defining function of DRAM1. The IBA annotation accurately captures the core function at the appropriate level of specificity. More specific terms (e.g., positive regulation of autophagosome-lysosome fusion) could be added as additional annotations but this general term correctly describes the overall role.
Supporting Evidence:
PMID:16839881
Here we describe DRAM (damage-regulated autophagy modulator), a p53 target gene encoding a lysosomal protein that induces macroautophagy
file:human/DRAM1/DRAM1-deep-research-falcon.md
DRAM1 directly stabilizes VAMP8, enabling STX17-SNAP29-VAMP8 assembly to drive autolysosome formation
|
|
GO:0005765
lysosomal membrane
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: This IEA annotation based on UniProt subcellular location mapping is well-supported. DRAM1 is a multi-pass lysosomal membrane protein with 6 transmembrane helices as annotated in UniProt. Experimental studies confirm the lysosomal membrane localization.
Reason: The IEA annotation correctly captures DRAM1's localization to the lysosomal membrane, which is experimentally verified. This is more specific than "lysosome" (GO:0005764) and appropriately indicates the membrane-bound nature of the protein consistent with its 6 transmembrane topology.
Supporting Evidence:
PMID:16839881
a p53 target gene encoding a lysosomal protein that induces macroautophagy
file:human/DRAM1/DRAM1-deep-research-falcon.md
DRAM1 is a conserved, multi-pass lysosomal membrane protein (six transmembrane segments)
|
|
GO:0006914
autophagy
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: This IEA annotation based on UniProt keyword mapping is appropriate. DRAM1's involvement in autophagy is central to its function, and while "regulation of autophagy" (GO:0010506) is more specific, this broader term is also accurate.
Reason: DRAM1 is directly involved in autophagy processes, particularly at the autophagosome-lysosome fusion step. While the IBA/IDA annotations for "regulation of autophagy" are more informative about DRAM1's regulatory role, this general autophagy annotation is not incorrect as DRAM1 is an integral component of the autophagy machinery.
Supporting Evidence:
PMID:16839881
a p53 target gene encoding a lysosomal protein that induces macroautophagy
|
|
GO:0006915
apoptotic process
|
IEA
GO_REF:0000043 |
KEEP AS NON CORE |
Summary: DRAM1 plays a critical role in p53-mediated apoptosis. The original discovery paper (Crighton et al., 2006) demonstrated that DRAM1 is required for p53-induced apoptosis, linking autophagy to programmed cell death. However, DRAM1 is not directly an apoptotic effector but rather modulates apoptosis through its autophagy regulatory function.
Reason: While DRAM1 contributes to p53-mediated apoptosis, this is secondary to its primary autophagy function. The original paper states DRAM1 is essential for p53-mediated apoptosis but this is through its autophagy-modulating activity. DRAM1 can also recruit BAX to lysosomes to trigger lysosomal membrane permeabilization in specific contexts. This annotation is valid but represents a downstream consequence rather than core molecular function.
Supporting Evidence:
PMID:16839881
while overexpression of DRAM alone causes minimal cell death, DRAM is essential for p53-mediated apoptosis
PMID:17304243
p73's ability to induce death, again different to p53, is neither dependent on DRAM nor autophagy
|
|
GO:0005515
protein binding
|
IPI
PMID:25416956 A proteome-scale map of the human interactome network |
MARK AS OVER ANNOTATED |
Summary: This annotation derives from a high-throughput yeast two-hybrid study (Rolland et al., 2014, Cell) that identified an interaction between DRAM1 and C1orf21. While technically valid, "protein binding" is uninformative about DRAM1's actual molecular function.
Reason: The term "protein binding" is too generic to be informative. DRAM1 has specific, functionally relevant protein interactions (e.g., VAMP8, STIM1) that should be annotated with more specific terms if possible. This high-throughput interaction with C1orf21 lacks functional validation and does not illuminate DRAM1's mechanism. While not incorrect, such generic annotations provide little biological insight.
Supporting Evidence:
PMID:25416956
A proteome-scale map of the human interactome network.
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome |
MARK AS OVER ANNOTATED |
Summary: This annotation derives from the HuRI (Human Reference Interactome) study which identified multiple DRAM1 protein interactions through systematic Y2H screening including GPR42, EVI2B, CLRN1, CD164L2, MS4A7, LRRC4C, and TIMMDC1.
Reason: Similar to the other protein binding annotation, this is too generic. The interactions identified in HuRI are from systematic screening without functional validation in the context of DRAM1's autophagy function. The mechanistically relevant interactions (VAMP8, STIM1) are better documented in the specialized literature.
Supporting Evidence:
PMID:32296183
Apr 8. A reference map of the human binary protein interactome.
|
|
GO:0090650
cellular response to oxygen-glucose deprivation
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: This IEA annotation was transferred from orthologous genes via Ensembl Compara. While autophagy is induced by metabolic stress including oxygen-glucose deprivation, and DRAM1 is known to be p53-induced under stress conditions, this specific annotation lacks direct experimental support for human DRAM1.
Reason: The annotation is plausible given DRAM1's role as a stress-responsive autophagy modulator that is induced by p53 activation. However, this represents a specific stress context rather than core function. The evidence is transferred from orthologs rather than direct experimental evidence for human DRAM1.
|
|
GO:0010506
regulation of autophagy
|
IDA
PMID:19895784 Reduced expression of DRAM2/TMEM77 in tumor cells interferes... |
ACCEPT |
Summary: CRITICAL ISSUE: PMID:19895784 (Park et al., 2009) is primarily about DRAM2/TMEM77, not DRAM1. The paper identifies DRAM2 as a DRAM-homologous protein and studies its lysosomal localization. While the paper mentions that co-expression of DRAM2 with DRAM (DRAM1) induces cell death, the primary focus is on DRAM2. Nevertheless, the annotation itself (regulation of autophagy for DRAM1) is correct based on other literature; this reference is just poorly chosen.
Reason: The annotation (regulation of autophagy) is correct for DRAM1 based on extensive literature evidence, even though this particular reference primarily characterizes DRAM2 rather than DRAM1. The core function is well-supported by other studies (PMID:16839881, PMID:17304243).
Supporting Evidence:
PMID:16839881
Here we describe DRAM (damage-regulated autophagy modulator), a p53 target gene encoding a lysosomal protein that induces macroautophagy
PMID:19895784
Reduced expression of DRAM2/TMEM77 in tumor cells interferes with cell death.
PMID:17304243
2007 Feb 16. p73 regulates DRAM-independent autophagy that does not contribute to programmed cell death.
|
|
GO:0005737
cytoplasm
|
IDA
PMID:19895784 Reduced expression of DRAM2/TMEM77 in tumor cells interferes... |
REMOVE |
Summary: This annotation citing cytoplasmic localization for DRAM1 based on PMID:19895784 is problematic. First, this paper primarily studies DRAM2, not DRAM1. Second, DRAM1 is specifically a lysosomal membrane protein - while the lysosome is within the cytoplasm, annotating DRAM1 to "cytoplasm" is misleading as it is a membrane-bound protein with specific organellar localization.
Reason: DRAM1 is a multi-pass transmembrane protein specifically localized to lysosomal membranes, not a cytoplasmic protein. This annotation is overly broad and misleading. The reference (PMID:19895784) primarily characterizes DRAM2, not DRAM1. The more appropriate localization terms (lysosome, lysosomal membrane) are already annotated.
Supporting Evidence:
file:human/DRAM1/DRAM1-deep-research-falcon.md
DRAM1 is a conserved, multi-pass lysosomal membrane protein (six transmembrane segments) whose C-terminus faces the cytosol
PMID:19895784
Reduced expression of DRAM2/TMEM77 in tumor cells interferes with cell death.
|
|
GO:0005764
lysosome
|
IDA
PMID:19895784 Reduced expression of DRAM2/TMEM77 in tumor cells interferes... |
ACCEPT |
Summary: While the lysosomal localization of DRAM1 is correct and well-supported by other literature (PMID:16839881), this specific reference (PMID:19895784) primarily characterizes DRAM2 rather than DRAM1. The annotation is valid but the reference is suboptimal; PMID:16839881 would be a better primary reference.
Reason: Lysosomal localization is a core, well-documented feature of DRAM1 supported by multiple studies. While PMID:19895784 primarily studies DRAM2 and mentions DRAM1 co-localization, better references exist (PMID:16839881). The IDA annotation is retained as the biological assertion is correct.
Supporting Evidence:
PMID:16839881
a p53 target gene encoding a lysosomal protein that induces macroautophagy
PMID:19895784
Reduced expression of DRAM2/TMEM77 in tumor cells interferes with cell death.
|
|
GO:0160177
positive regulation of autophagosome-lysosome fusion
|
IDA
DOI:10.1038/s41467-025-60887-y |
NEW |
Summary: Recent mechanistic studies (Zhang et al., 2025 Nature Communications) demonstrate that DRAM1 promotes autophagosome-lysosome fusion by stabilizing lysosomal VAMP8. DRAM1 binds VAMP8 and blocks CHIP-mediated ubiquitination at Lys68/72/75, enabling assembly of the STX17-SNAP29-VAMP8 SNARE complex required for autophagosome-lysosome fusion.
Reason: This annotation captures the specific mechanism by which DRAM1 regulates autophagy. While GO:0010506 (regulation of autophagy) is already annotated, this more specific term accurately describes the molecular function revealed by recent research. The evidence is from a 2025 Nature Communications paper with detailed biochemical characterization.
Supporting Evidence:
file:human/DRAM1/DRAM1-deep-research-falcon.md
DRAM1 directly stabilizes VAMP8, enabling STX17-SNAP29-VAMP8 assembly to drive autolysosome formation
|
|
GO:0000149
SNARE binding
|
IDA
DOI:10.1038/s41467-025-60887-y |
NEW |
Summary: Zhang et al. (2025) demonstrated that DRAM1 directly binds VAMP8, a SNARE protein (R-SNARE/v-SNARE) on lysosomes. This interaction is essential for DRAM1's function in promoting autophagosome-lysosome fusion.
Reason: This MF term captures the specific molecular interaction underlying DRAM1's function. VAMP8 is a well-characterized SNARE protein, and DRAM1 binding to it is mechanistically important for autolysosome formation. This is more informative than generic "protein binding".
Supporting Evidence:
file:human/DRAM1/DRAM1-deep-research-falcon.md
DRAM1 binds and stabilizes lysosomal VAMP8 by blocking CHIP-mediated ubiquitination (Lys68/72/75)
|
|
GO:1904417
positive regulation of xenophagy
|
IMP
DOI:10.3389/fcimb.2023.1331818 |
NEW |
Summary: Studies in zebrafish show that dram1 overexpression enhances xenophagy-mediated defense against Mycobacterium marinum infection, increasing LC3 recruitment and acidification of mycobacteria-containing compartments (Xie & Meijer, 2024).
Reason: Xenophagy (selective autophagy of intracellular pathogens) is a specific biological role for DRAM1 in host defense. While this evidence is from zebrafish, DRAM1 is conserved and this function is likely relevant to the human protein as well, particularly given the TLR-MYD88-NF-kB regulation pathway.
Supporting Evidence:
file:human/DRAM1/DRAM1-deep-research-falcon.md
dram1 mRNA overexpression increased LC3 colocalization with Mycobacterium marinum and reduced pathogen burden
|
Q: What is the structure of DRAM1 and how does it interact with VAMP8?
Q: Does DRAM1 have any enzymatic activity or is it purely an adapter/scaffold?
Q: How is DRAM1 trafficking from Golgi to lysosomes regulated beyond AP-4?
Q: What determines whether DRAM1 promotes protective autophagy vs apoptosis?
Experiment: Structural studies (cryo-EM or crystallography) of DRAM1-VAMP8 complex
Hypothesis: Determine the molecular basis of DRAM1-VAMP8 interaction
Experiment: Functional studies of DRAM1 in human xenophagy (bacterial infection models)
Hypothesis: Confirm xenophagy function demonstrated in zebrafish also applies to human DRAM1
Experiment: Proximity labeling (BioID/APEX) to identify full DRAM1 interactome at lysosomes
Hypothesis: Identify additional DRAM1 interaction partners at lysosomal membranes
Experiment: CRISPR screens to identify synthetic lethal interactions with DRAM1 in autophagy-dependent cancer
Hypothesis: Identify therapeutic targets that synergize with DRAM1 loss
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-01-19T08:57:50.481354'
end_time: '2026-01-19T09:03:56.630160'
duration_seconds: 366.15
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: DRAM1
gene_symbol: DRAM1
uniprot_accession: Q8N682
protein_description: 'RecName: Full=DNA damage-regulated autophagy modulator protein
1; AltName: Full=Damage-regulated autophagy modulator;'
gene_info: Name=DRAM1; Synonyms=DRAM;
organism_full: Homo sapiens (Human).
protein_family: Belongs to the DRAM/TMEM150 family. .
protein_domains: DRAM/TMEM150_Autophagy_Mod. (IPR050911); Frag1/DRAM/Sfk1. (IPR019402);
Frag1 (PF10277)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 14
BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.
DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'DRAM1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information
Please provide a comprehensive research report on the gene DRAM1 (gene ID: DRAM1, UniProt: Q8N682) in human.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Question: You are an expert researcher providing comprehensive, well-cited information.
Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies
Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.
BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.
DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'DRAM1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information
Please provide a comprehensive research report on the gene DRAM1 (gene ID: DRAM1, UniProt: Q8N682) in human.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Plan and verification
We verified that the requested target is the human gene DRAM1 (DNA damage-regulated autophagy modulator 1; UniProt Q8N682). Recent primary literature characterizes DRAM1 as a conserved, multi-pass lysosomal membrane protein and canonical p53 target, consistent with the human UniProt entry and the DRAM/TMEM family description. Human-cell studies (HEK293T, U2OS) and in vivo models (Drosophila) localize the full-length human DRAM1 to LAMP1-positive lysosomes with six hydrophobic transmembrane segments and a cytosol-facing C-terminus, matching the expected topological class for this family (PNAS 2024) (wang2024thep53target pages 1-2, wang2024thep53target pages 3-3, wang2024thep53target pages 3-4, wang2024thep53target pages 9-10). No conflicting gene symbol usage was identified in the 2023–2024 literature.
1) Key concepts and definitions (current understanding)
- Identity and topology: DRAM1 is a conserved, multi-pass lysosomal membrane protein (six transmembrane segments) whose C-terminus faces the cytosol. It resides primarily on lysosomes with partial localization to late endosomes and autophagosomes. Proper lysosomal targeting involves adaptor protein complexes, with AP-4 playing a major role (human cells) (PNAS, 2024) (wang2024thep53target pages 3-3, wang2024thep53target pages 3-4, wang2024thep53target pages 9-10).
- Primary role in autophagy/lysosome biology: DRAM1 is a canonical p53-induced factor that promotes autophagy and lysosomal function. Mechanistically, DRAM1 can (i) enhance lysosomal acidification and protease activation, (ii) promote autophagosome–lysosome fusion and autolysosome formation, and (iii) engage selective autophagy programs, including ER-phagy; it can also recruit BAX to lysosomes to trigger lysosomal membrane permeabilization in specific contexts (PNAS, 2024; Nat Commun, 2025) (wang2024thep53target pages 9-10, zhang2025dram1promotesthe pages 1-2).
- Cargo/pathway selectivity: DRAM1 modulates selective autophagy programs beyond bulk autophagy. In 2024, DRAM1 was shown to regulate ER–lysosome contact sites through STIM1, coupling lysosomal function to ER stress and ER-phagy. Prior and concurrent data connect DRAM1 to mitophagy-relevant stress responses in Parkinsonian models, and to xenophagy defenses in mycobacterial infection models (PNAS, 2024; Front Cell Infect Microbiol, 2024) (wang2024thep53target pages 1-2, wang2024thep53target pages 3-3, xie2024xenophagyreceptorsoptn pages 8-10).
- Upstream regulation: DRAM1 is transcriptionally induced by p53 (human cancer cell lines; knockdown of p53 lowers DRAM1 mRNA and protein). In innate immunity, Dram1 lies downstream of TLR–MYD88–NF-κB signaling in zebrafish infection models, positioning it within a stress- and pathogen-responsive regulatory network (Sci Rep, 2025; Front Cell Infect Microbiol, 2024) (wu2025dram1enhancesthe pages 15-16, xie2024xenophagyreceptorsoptn pages 8-10).
2) Recent developments and latest research (prioritizing 2023–2024)
- ER–lysosome contact sites and Ca2+ homeostasis: A 2024 PNAS study demonstrated that DRAM1 physically and functionally promotes ER–lysosome contacts via STIM1, disrupting ER structure, triggering ER stress, and inducing ER-phagy; overexpression of STIM1 mitigated these effects. The work links DRAM1 to calcium homeostasis and organelle contact-site biology, establishing roles beyond classical autophagy induction (PNAS, 2024; published Sept 18, 2024; https://doi.org/10.1073/pnas.2400531121) (wang2024thep53target pages 1-2, wang2024thep53target pages 9-10).
- Autolysosome formation via VAMP8 stabilization: A 2025 Nature Communications study (received 2024) revealed that DRAM1 binds and stabilizes lysosomal VAMP8 by blocking CHIP-mediated ubiquitination (Lys68/72/75). DRAM1 thereby promotes assembly of the STX17–SNAP29–VAMP8 SNARE complex, enhancing autophagosome–lysosome fusion (Nat Commun, 2025; https://doi.org/10.1038/s41467-025-60887-y) (zhang2025dram1promotesthe pages 1-2, zhang2025dram1promotesthe pages 8-9).
- Cancer signaling and metabolism: In gastric cancer models (2024–2025), DRAM1 promoted proliferation, migration/metastasis, and metabolic reprogramming via PI3K/AKT/mTOR signaling; DRAM1 knockdown decreased p-AKT/p-mTOR and curtailed tumor growth in vivo (Scientific Reports, 2025; accepted Jan 20, 2025; https://doi.org/10.1038/s41598-025-87389-7) (wu2025dram1enhancesthe pages 15-16, wu2025dram1enhancesthe pages 4-5, wu2025dram1enhancesthe pages 3-4, wu2025dram1enhancesthe pages 5-7).
- Neurodegeneration context: A 2025 review synthesized how DRAM1-mediated ER–lysosome tethering and lysosomal dysfunction intersect with endomembrane network failure in neurodegenerative diseases, integrating the 2024 PNAS findings into disease mechanisms (Exp Mol Med, 2025; https://doi.org/10.1038/s12276-025-01579-x) (kim2025failureoflysosomal pages 10-10).
3) Current applications and real-world implementations
- Cancer models: Genetic suppression of DRAM1 reduced in vivo tumor growth in nude mouse xenograft models of gastric cancer, consistent with attenuated PI3K/AKT/mTOR signaling. The study also explored pharmacologic interactions (e.g., PI3K inhibitor LY294002, rapamycin) that intersect with DRAM1-driven phenotypes, suggesting combinatorial therapeutic avenues (Scientific Reports, 2025) (wu2025dram1enhancesthe pages 3-4, wu2025dram1enhancesthe pages 5-7).
- Infection models (xenophagy): In zebrafish infected with Mycobacterium marinum, dram1 mRNA overexpression reduced bacterial burden and increased LC3 recruitment and acidification of Mm-containing compartments. Dram1 action was independent of optn and p62 (double mutants) but required myd88, providing an in vivo proof-of-principle of host-directed, DRAM1-mediated xenophagy enhancement (Front Cell Infect Microbiol, 2024; https://doi.org/10.3389/fcimb.2023.1331818) (xie2024xenophagyreceptorsoptn pages 12-12, xie2024xenophagyreceptorsoptn pages 8-10).
- Organellar contacts and stress modulation: The 2024 mechanistic PNAS work suggests that manipulating DRAM1–STIM1 interactions could modulate ER stress and ER-phagy, presenting a potential avenue for therapeutic modulation of stress-responsive autophagy pathways in degenerative diseases and cancer (PNAS, 2024) (wang2024thep53target pages 1-2, wang2024thep53target pages 9-10).
4) Expert opinions and analysis from authoritative sources
- Authoritative autophagy–cancer review: Nature Reviews Molecular Cell Biology (2023) frames DRAM1 as a canonical p53 target within autophagy networks that can take tumor-suppressive or tumor-promoting roles depending on context, aligning with the dual roles seen in recent gastric and liver cancer models (Nat Rev Mol Cell Biol, 2023; https://doi.org/10.1038/s41580-023-00585-z) ().
- Mechanistic novelty and disease linkage: The 2024 PNAS paper places DRAM1 at ER–lysosome contact sites via STIM1, extending DRAM1’s role to calcium and ER-stress control. A 2025 review integrates these findings into broader neurodegenerative disease models, underscoring lysosomal acidification and contact site physiology as therapeutic targets (PNAS, 2024; Exp Mol Med, 2025) (wang2024thep53target pages 1-2, kim2025failureoflysosomal pages 10-10).
- Cancer cell-extravasation pathway: The 2025 Nature Communications paper provides a mechanistic model whereby DRAM1 promotes autolysosome formation via VAMP8 stabilization, linking enhanced autophagic flux to metastatic extravasation in HCC—thereby identifying a druggable axis (VAMP8 ubiquitination/CHIP interaction) for anti-metastatic strategies (Nat Commun, 2025) (zhang2025dram1promotesthe pages 1-2, zhang2025dram1promotesthe pages 8-9).
5) Relevant statistics and data from recent studies
- DRAM1–p53 regulation (gastric cancer cells): p53 knockdown significantly reduced DRAM1 mRNA in AGS and HGC27 cells (e.g., AGS sip53-1 and sip53-2 vs control, p<0.001; HGC27, p=0.002) and lowered DRAM1 protein (Scientific Reports, 2025) (wu2025dram1enhancesthe pages 15-16).
- In vivo tumor suppression by DRAM1 knockdown: In male nude mouse xenografts, DRAM1 knockdown “significantly reduced the growth rate, size, and weight” of tumors and increased TUNEL-positive apoptosis; DRAM1 knockdown decreased PI3K/AKT/mTOR pathway readouts in tumor tissue (Scientific Reports, 2025) (wu2025dram1enhancesthe pages 3-4).
- Zebrafish xenophagy enhancement by dram1 overexpression: One-cell-stage dram1 mRNA overexpression increased LC3 colocalization with Mycobacterium marinum and reduced pathogen burden at 2 dpi; effects remained in optn/p62 double mutants but were absent in myd88 mutants, indicating dependence on innate TLR signaling (Front Cell Infect Microbiol, 2024) (xie2024xenophagyreceptorsoptn pages 8-10).
Mechanistic integration and pathway placement
- Upstream: DNA damage and other stresses activate p53, which transactivates DRAM1. In innate immune contexts, TLR–MYD88–NF-κB signaling can upregulate Dram1 (zebrafish) (Sci Rep, 2025; Front Cell Infect Microbiol, 2024) (wu2025dram1enhancesthe pages 15-16, xie2024xenophagyreceptorsoptn pages 8-10).
- Localization/topology: DRAM1 is a lysosomal multi-pass membrane protein (6 TMs) with a cytosolic C-terminus; it also partially localizes to RAB7-positive late endosomes and LC3-positive autophagosomes. AP-4 contributes to DRAM1 trafficking from the Golgi to lysosomes (PNAS, 2024) (wang2024thep53target pages 3-3, wang2024thep53target pages 3-4, wang2024thep53target pages 9-10).
- Autophagosome–lysosome fusion: DRAM1 directly stabilizes VAMP8, enabling STX17–SNAP29–VAMP8 assembly to drive autolysosome formation; this fusion step links DRAM1 to maturation of the autophagic pathway (Nat Commun, 2025) (zhang2025dram1promotesthe pages 1-2, zhang2025dram1promotesthe pages 8-9).
- Organelle contact sites and Ca2+ signaling: DRAM1 promotes ER–lysosome contacts through STIM1, altering Ca2+ homeostasis, ER stress, and ER-phagy signaling (PNAS, 2024) (wang2024thep53target pages 1-2, wang2024thep53target pages 9-10).
- Downstream cellular outcomes: In cancer, DRAM1 intersects with PI3K/AKT/mTOR and EMT programs (GC models), and in HCC models contributes to extravasation via enhanced autolysosome formation; in infection, DRAM1 promotes xenophagy and lysosomal acidification of mycobacteria-containing compartments; in neuronal stress models, DRAM1 modifies mitochondrial/ER stress responses (Sci Rep, 2025; Nat Commun, 2025; Front Cell Infect Microbiol, 2024; PNAS, 2024) (wu2025dram1enhancesthe pages 15-16, zhang2025dram1promotesthe pages 1-2, xie2024xenophagyreceptorsoptn pages 12-12, xie2024xenophagyreceptorsoptn pages 8-10, wang2024thep53target pages 1-2, wang2024thep53target pages 3-3).
Limitations and open questions
- While strong evidence supports p53-mediated regulation and lysosomal/autophagic functions, comprehensive human clinical expression statistics (IHC prevalence, hazard ratios) remain limited in recent mechanistic reports; larger clinical cohorts and multi-omic integration will be valuable. The extent to which DRAM1 modulates additional selective autophagy processes (e.g., mitophagy vs ER-phagy vs xenophagy) in human tissues remains an active area of investigation (PNAS, 2024; Front Cell Infect Microbiol, 2024; Sci Rep, 2025) (wang2024thep53target pages 1-2, xie2024xenophagyreceptorsoptn pages 8-10, wu2025dram1enhancesthe pages 15-16).
Embedded summary of recent studies
| Year | Study (first author + journal) | System/Model | Mechanistic focus | Disease/Context | Key quantitative/qualitative outcomes | URL/DOI |
|---:|---|---|---|---|---|---|
| 2024 | Wang et al., PNAS (Proc. Natl. Acad. Sci. USA) (wang2024thep53target pages 1-2) | HEK293T, U2OS, Drosophila, PD mitochondrial-stress models | STIM1-mediated ER–lysosome contacts; DRAM1 tethering; Ca2+ homeostasis; ER-phagy; lysosomal acidification | Cellular stress; neurodegeneration models; autophagy regulation | DRAM1 promotes ER–lysosome contacts via STIM1, perturbs Ca2+ handling and induces ER stress/ER-phagy; STIM1 overexpression mitigates DRAM1 effects (mechanistic cell and in vivo evidence) (wang2024thep53target pages 1-2) | https://doi.org/10.1073/pnas.2400531121 |
| 2025 | Wu et al., Scientific Reports (wu2025dram1enhancesthe pages 15-16, wu2025dram1enhancesthe pages 4-5) | Gastric cancer cell lines; AGS xenograft mice | PI3K/AKT/mTOR signaling modulation; metabolic reprogramming; p53 → DRAM1 axis | Gastric cancer (proliferation, metastasis) | DRAM1 knockdown reduced in vivo tumor growth and increased TUNEL-positive apoptosis; decreased p-AKT/p-mTOR and impaired migration/invasion (in vitro + xenograft) (wu2025dram1enhancesthe pages 15-16) | https://doi.org/10.1038/s41598-025-87389-7 |
| 2025 | Zhang et al., Nature Communications (zhang2025dram1promotesthe pages 1-2) | Cell lines; biochemical assays; HCC extravasation in vivo models | Direct DRAM1–VAMP8 interaction; stabilization of lysosomal VAMP8; promotes STX17–SNAP29–VAMP8 SNARE assembly → autolysosome formation | Hepatocellular carcinoma (extravasation/metastasis) | DRAM1 inhibits CHIP-mediated ubiquitination of VAMP8 (Lys68/72/75), stabilizes lysosomal VAMP8, enhances autophagosome–lysosome fusion and promotes HCC extravasation (mechanistic + in vivo metastasis phenotype) (zhang2025dram1promotesthe pages 1-2) | https://doi.org/10.1038/s41467-025-60887-y |
| 2025 | Kim et al., Experimental & Molecular Medicine (review) (kim2025failureoflysosomal pages 10-10) | Review (literature synthesis) | Contextualizes DRAM1 in lysosomal acidification and ER–lysosome/endomembrane network dysfunction | Neurodegenerative disease contexts (PD, AD) | Synthesizes evidence that DRAM1-mediated ER–lysosome tethering and lysosomal dysregulation contribute to neurodegeneration; highlights lysosomal acidification failure as pathogenic mechanism (kim2025failureoflysosomal pages 10-10) | https://doi.org/10.1038/s12276-025-01579-x |
Table: A compact summary table of recent, mechanistic DRAM1 studies (primary research and review) showing models used, core mechanisms (ER–lysosome contacts, VAMP8 stabilization, PI3K/AKT/mTOR links), disease contexts, and key outcomes with DOI links and source citations for rapid reference.
References (URLs and dates where available)
- Wang et al. The p53 target DRAM1 modulates calcium homeostasis and ER stress by promoting contact between lysosomes and the ER through STIM1. PNAS. Published Sept 18, 2024. https://doi.org/10.1073/pnas.2400531121 (wang2024thep53target pages 1-2, wang2024thep53target pages 3-3, wang2024thep53target pages 3-4, wang2024thep53target pages 9-10)
- Zhang et al. DRAM1 promotes the stability of lysosomal VAMP8 to enhance autolysosome formation and facilitates the extravasation. Nature Communications. Published July 2025 (received 2024). https://doi.org/10.1038/s41467-025-60887-y (zhang2025dram1promotesthe pages 1-2, zhang2025dram1promotesthe pages 8-9)
- Wu et al. DRAM1 enhances the proliferation and metastasis of gastric cancer through the PI3K/AKT/mTOR signaling pathway and energy metabolism. Scientific Reports. Accepted Jan 20, 2025. https://doi.org/10.1038/s41598-025-87389-7 (wu2025dram1enhancesthe pages 15-16, wu2025dram1enhancesthe pages 4-5, wu2025dram1enhancesthe pages 3-4, wu2025dram1enhancesthe pages 5-7)
- Xie & Meijer. Xenophagy receptors Optn and p62 and autophagy modulator Dram1 independently promote the zebrafish host defense against Mycobacterium marinum. Frontiers in Cellular and Infection Microbiology. Published Jan 2024. https://doi.org/10.3389/fcimb.2023.1331818 (xie2024xenophagyreceptorsoptn pages 12-12, xie2024xenophagyreceptorsoptn pages 8-10)
- Kim et al. Failure of lysosomal acidification and endomembrane network in neurodegeneration. Experimental & Molecular Medicine. Published Nov 2025. https://doi.org/10.1038/s12276-025-01579-x (kim2025failureoflysosomal pages 10-10)
- Debnath et al. Autophagy and autophagy-related pathways in cancer. Nature Reviews Molecular Cell Biology. 2023. https://doi.org/10.1038/s41580-023-00585-z ()
References
(wang2024thep53target pages 1-2): Xiying Wang, Ji Geng, Suman Rimal, Yuxiu Sui, Jie Pan, Zhenghong Qin, and Bingwei Lu. The p53 target dram1 modulates calcium homeostasis and er stress by promoting contact between lysosomes and the er through stim1. Proceedings of the National Academy of Sciences of the United States of America, Sep 2024. URL: https://doi.org/10.1073/pnas.2400531121, doi:10.1073/pnas.2400531121. This article has 6 citations and is from a highest quality peer-reviewed journal.
(wang2024thep53target pages 3-3): Xiying Wang, Ji Geng, Suman Rimal, Yuxiu Sui, Jie Pan, Zhenghong Qin, and Bingwei Lu. The p53 target dram1 modulates calcium homeostasis and er stress by promoting contact between lysosomes and the er through stim1. Proceedings of the National Academy of Sciences of the United States of America, Sep 2024. URL: https://doi.org/10.1073/pnas.2400531121, doi:10.1073/pnas.2400531121. This article has 6 citations and is from a highest quality peer-reviewed journal.
(wang2024thep53target pages 3-4): Xiying Wang, Ji Geng, Suman Rimal, Yuxiu Sui, Jie Pan, Zhenghong Qin, and Bingwei Lu. The p53 target dram1 modulates calcium homeostasis and er stress by promoting contact between lysosomes and the er through stim1. Proceedings of the National Academy of Sciences of the United States of America, Sep 2024. URL: https://doi.org/10.1073/pnas.2400531121, doi:10.1073/pnas.2400531121. This article has 6 citations and is from a highest quality peer-reviewed journal.
(wang2024thep53target pages 9-10): Xiying Wang, Ji Geng, Suman Rimal, Yuxiu Sui, Jie Pan, Zhenghong Qin, and Bingwei Lu. The p53 target dram1 modulates calcium homeostasis and er stress by promoting contact between lysosomes and the er through stim1. Proceedings of the National Academy of Sciences of the United States of America, Sep 2024. URL: https://doi.org/10.1073/pnas.2400531121, doi:10.1073/pnas.2400531121. This article has 6 citations and is from a highest quality peer-reviewed journal.
(zhang2025dram1promotesthe pages 1-2): Rui Zhang, Xin Zhang, Hua Bai, Qiuyu Cheng, Xia Yao, Shi Li, Vincenzo Torraca, Chaojun Yan, Xueying Dong, Siyi Miao, Xueyuan Hu, Yeping Yu, Yueyan Wu, Hongfei Tan, Xin Chen, Shicheng Liu, Hao Lyu, Shuai Xiao, Dong Guo, Qi Zhang, Xing-Zhen Chen, Zhiyin Song, Cefan Zhou, and Jingfeng Tang. Dram1 promotes the stability of lysosomal vamp8 to enhance autolysosome formation and facilitates the extravasation. Nature Communications, Jul 2025. URL: https://doi.org/10.1038/s41467-025-60887-y, doi:10.1038/s41467-025-60887-y. This article has 6 citations and is from a highest quality peer-reviewed journal.
(xie2024xenophagyreceptorsoptn pages 8-10): Jiajun Xie and Annemarie H. Meijer. Xenophagy receptors optn and p62 and autophagy modulator dram1 independently promote the zebrafish host defense against mycobacterium marinum. Frontiers in Cellular and Infection Microbiology, Jan 2024. URL: https://doi.org/10.3389/fcimb.2023.1331818, doi:10.3389/fcimb.2023.1331818. This article has 11 citations and is from a poor quality or predatory journal.
(wu2025dram1enhancesthe pages 15-16): Xinrong Wu, Yifan Li, Weiwei Wang, Jiale Xu, Bei Zhao, Wenqi Sun, Dan Ge, Longying Xiong, Xiaotan Dou, Xiaoping Zou, Lei Wang, and Min Chen. Dram1 enhances the proliferation and metastasis of gastric cancer through the pi3k/akt/mtor signaling pathway and energy metabolism. Scientific Reports, Jan 2025. URL: https://doi.org/10.1038/s41598-025-87389-7, doi:10.1038/s41598-025-87389-7. This article has 3 citations and is from a peer-reviewed journal.
(zhang2025dram1promotesthe pages 8-9): Rui Zhang, Xin Zhang, Hua Bai, Qiuyu Cheng, Xia Yao, Shi Li, Vincenzo Torraca, Chaojun Yan, Xueying Dong, Siyi Miao, Xueyuan Hu, Yeping Yu, Yueyan Wu, Hongfei Tan, Xin Chen, Shicheng Liu, Hao Lyu, Shuai Xiao, Dong Guo, Qi Zhang, Xing-Zhen Chen, Zhiyin Song, Cefan Zhou, and Jingfeng Tang. Dram1 promotes the stability of lysosomal vamp8 to enhance autolysosome formation and facilitates the extravasation. Nature Communications, Jul 2025. URL: https://doi.org/10.1038/s41467-025-60887-y, doi:10.1038/s41467-025-60887-y. This article has 6 citations and is from a highest quality peer-reviewed journal.
(wu2025dram1enhancesthe pages 4-5): Xinrong Wu, Yifan Li, Weiwei Wang, Jiale Xu, Bei Zhao, Wenqi Sun, Dan Ge, Longying Xiong, Xiaotan Dou, Xiaoping Zou, Lei Wang, and Min Chen. Dram1 enhances the proliferation and metastasis of gastric cancer through the pi3k/akt/mtor signaling pathway and energy metabolism. Scientific Reports, Jan 2025. URL: https://doi.org/10.1038/s41598-025-87389-7, doi:10.1038/s41598-025-87389-7. This article has 3 citations and is from a peer-reviewed journal.
(wu2025dram1enhancesthe pages 3-4): Xinrong Wu, Yifan Li, Weiwei Wang, Jiale Xu, Bei Zhao, Wenqi Sun, Dan Ge, Longying Xiong, Xiaotan Dou, Xiaoping Zou, Lei Wang, and Min Chen. Dram1 enhances the proliferation and metastasis of gastric cancer through the pi3k/akt/mtor signaling pathway and energy metabolism. Scientific Reports, Jan 2025. URL: https://doi.org/10.1038/s41598-025-87389-7, doi:10.1038/s41598-025-87389-7. This article has 3 citations and is from a peer-reviewed journal.
(wu2025dram1enhancesthe pages 5-7): Xinrong Wu, Yifan Li, Weiwei Wang, Jiale Xu, Bei Zhao, Wenqi Sun, Dan Ge, Longying Xiong, Xiaotan Dou, Xiaoping Zou, Lei Wang, and Min Chen. Dram1 enhances the proliferation and metastasis of gastric cancer through the pi3k/akt/mtor signaling pathway and energy metabolism. Scientific Reports, Jan 2025. URL: https://doi.org/10.1038/s41598-025-87389-7, doi:10.1038/s41598-025-87389-7. This article has 3 citations and is from a peer-reviewed journal.
(kim2025failureoflysosomal pages 10-10): Seo-Hyun Kim, Young-Sin Cho, and Yong-Keun Jung. Failure of lysosomal acidification and endomembrane network in neurodegeneration. Experimental & Molecular Medicine, 57:2418-2428, Nov 2025. URL: https://doi.org/10.1038/s12276-025-01579-x, doi:10.1038/s12276-025-01579-x. This article has 1 citations and is from a peer-reviewed journal.
(xie2024xenophagyreceptorsoptn pages 12-12): Jiajun Xie and Annemarie H. Meijer. Xenophagy receptors optn and p62 and autophagy modulator dram1 independently promote the zebrafish host defense against mycobacterium marinum. Frontiers in Cellular and Infection Microbiology, Jan 2024. URL: https://doi.org/10.3389/fcimb.2023.1331818, doi:10.3389/fcimb.2023.1331818. This article has 11 citations and is from a poor quality or predatory journal.
id: Q8N682
gene_symbol: DRAM1
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >
DRAM1 (DNA damage-regulated autophagy modulator protein 1) is a lysosomal multi-pass
membrane
protein with six transmembrane segments, primarily localized to LAMP1-positive lysosomes
with
its C-terminus facing the cytosol. It is a canonical p53-induced autophagy modulator
that
plays central roles in: (1) promoting autophagosome-lysosome fusion via stabilization
of
lysosomal VAMP8 by blocking CHIP-mediated ubiquitination, thereby enabling STX17-SNAP29-VAMP8
SNARE complex assembly; (2) regulating ER-lysosome membrane contact sites through
interaction
with STIM1, affecting calcium homeostasis and ER-phagy; (3) enhancing lysosomal
acidification
and protease activation; and (4) promoting xenophagy (antimicrobial autophagy) in
host defense
against intracellular pathogens such as mycobacteria. DRAM1 is transcriptionally
activated by
p53 and p73, and is down-regulated in tumor cells by methylation-dependent transcriptional
silencing. While DRAM1 is best characterized as a positive regulator of autophagy
and
p53-mediated apoptosis, its precise enzymatic function remains unclear; it appears
to act
primarily as an adapter/scaffold protein facilitating autophagy machinery assembly
and
organelle contact site formation.
existing_annotations:
- term:
id: GO:0005764
label: lysosome
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >
DRAM1 is a well-established lysosomal membrane protein. The IBA annotation
based on
phylogenetic analysis is strongly supported by multiple experimental studies
showing
DRAM1 localization to LAMP1-positive lysosomes (Wang et al., 2024 PNAS; Crighton
et al.,
2006 Cell PMID:16839881). UniProt also annotates DRAM1 to the lysosomal membrane
based
on experimental evidence.
action: ACCEPT
reason: >
Lysosomal localization is a core, well-documented feature of DRAM1. The protein
contains
6 transmembrane segments and resides primarily on lysosomes with partial localization
to
late endosomes and autophagosomes. This is supported by the original discovery
paper
(PMID:16839881) and recent mechanistic studies.
supported_by:
- reference_id: PMID:16839881
supporting_text: "Here we describe DRAM (damage-regulated autophagy modulator),
a p53 target gene encoding a lysosomal protein that induces macroautophagy"
- reference_id: file:human/DRAM1/DRAM1-deep-research-falcon.md
supporting_text: "DRAM1 is a conserved, multi-pass lysosomal membrane protein
(six transmembrane segments) whose C-terminus faces the cytosol. It resides
primarily on lysosomes with partial localization to late endosomes and
autophagosomes."
- term:
id: GO:0010506
label: regulation of autophagy
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >
DRAM1 is a canonical autophagy modulator, as indicated by its full name "DNA
damage-regulated autophagy modulator protein 1". Multiple mechanistic studies
confirm
DRAM1 regulates autophagy at multiple levels including autophagosome-lysosome
fusion
(via VAMP8 stabilization) and ER-phagy (via STIM1 interaction).
action: ACCEPT
reason: >
Regulation of autophagy is the primary, defining function of DRAM1. The IBA
annotation
accurately captures the core function at the appropriate level of specificity.
More
specific terms (e.g., positive regulation of autophagosome-lysosome fusion)
could be
added as additional annotations but this general term correctly describes
the overall
role.
supported_by:
- reference_id: PMID:16839881
supporting_text: "Here we describe DRAM (damage-regulated autophagy modulator),
a p53 target gene encoding a lysosomal protein that induces macroautophagy"
- reference_id: file:human/DRAM1/DRAM1-deep-research-falcon.md
supporting_text: "DRAM1 directly stabilizes VAMP8, enabling STX17-SNAP29-VAMP8
assembly to drive autolysosome formation"
- term:
id: GO:0005765
label: lysosomal membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: >
This IEA annotation based on UniProt subcellular location mapping is well-supported.
DRAM1 is a multi-pass lysosomal membrane protein with 6 transmembrane helices
as
annotated in UniProt. Experimental studies confirm the lysosomal membrane
localization.
action: ACCEPT
reason: >
The IEA annotation correctly captures DRAM1's localization to the lysosomal
membrane,
which is experimentally verified. This is more specific than "lysosome" (GO:0005764)
and appropriately indicates the membrane-bound nature of the protein consistent
with
its 6 transmembrane topology.
supported_by:
- reference_id: PMID:16839881
supporting_text: "a p53 target gene encoding a lysosomal protein that induces
macroautophagy"
- reference_id: file:human/DRAM1/DRAM1-deep-research-falcon.md
supporting_text: "DRAM1 is a conserved, multi-pass lysosomal membrane protein
(six transmembrane segments)"
- term:
id: GO:0006914
label: autophagy
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >
This IEA annotation based on UniProt keyword mapping is appropriate. DRAM1's
involvement in autophagy is central to its function, and while "regulation
of autophagy"
(GO:0010506) is more specific, this broader term is also accurate.
action: ACCEPT
reason: >
DRAM1 is directly involved in autophagy processes, particularly at the
autophagosome-lysosome fusion step. While the IBA/IDA annotations for "regulation
of
autophagy" are more informative about DRAM1's regulatory role, this general
autophagy
annotation is not incorrect as DRAM1 is an integral component of the autophagy
machinery.
supported_by:
- reference_id: PMID:16839881
supporting_text: "a p53 target gene encoding a lysosomal protein that induces
macroautophagy"
- term:
id: GO:0006915
label: apoptotic process
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >
DRAM1 plays a critical role in p53-mediated apoptosis. The original discovery
paper
(Crighton et al., 2006) demonstrated that DRAM1 is required for p53-induced
apoptosis,
linking autophagy to programmed cell death. However, DRAM1 is not directly
an apoptotic
effector but rather modulates apoptosis through its autophagy regulatory function.
action: KEEP_AS_NON_CORE
reason: >
While DRAM1 contributes to p53-mediated apoptosis, this is secondary to its
primary
autophagy function. The original paper states DRAM1 is essential for p53-mediated
apoptosis but this is through its autophagy-modulating activity. DRAM1 can
also
recruit BAX to lysosomes to trigger lysosomal membrane permeabilization in
specific
contexts. This annotation is valid but represents a downstream consequence
rather
than core molecular function.
supported_by:
- reference_id: PMID:16839881
supporting_text: "while overexpression of DRAM alone causes minimal cell
death, DRAM is essential for p53-mediated apoptosis"
- reference_id: PMID:17304243
supporting_text: "p73's ability to induce death, again different to p53,
is neither dependent on DRAM nor autophagy"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:25416956
review:
summary: >
This annotation derives from a high-throughput yeast two-hybrid study (Rolland
et al.,
2014, Cell) that identified an interaction between DRAM1 and C1orf21. While
technically
valid, "protein binding" is uninformative about DRAM1's actual molecular function.
action: MARK_AS_OVER_ANNOTATED
reason: >
The term "protein binding" is too generic to be informative. DRAM1 has specific,
functionally relevant protein interactions (e.g., VAMP8, STIM1) that should
be
annotated with more specific terms if possible. This high-throughput interaction
with C1orf21 lacks functional validation and does not illuminate DRAM1's mechanism.
While not incorrect, such generic annotations provide little biological insight.
additional_reference_ids:
- PMID:25416956
supported_by:
- reference_id: PMID:25416956
supporting_text: A proteome-scale map of the human interactome
network.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
review:
summary: >
This annotation derives from the HuRI (Human Reference Interactome) study
which
identified multiple DRAM1 protein interactions through systematic Y2H screening
including GPR42, EVI2B, CLRN1, CD164L2, MS4A7, LRRC4C, and TIMMDC1.
action: MARK_AS_OVER_ANNOTATED
reason: >
Similar to the other protein binding annotation, this is too generic. The
interactions
identified in HuRI are from systematic screening without functional validation
in the
context of DRAM1's autophagy function. The mechanistically relevant interactions
(VAMP8, STIM1) are better documented in the specialized literature.
additional_reference_ids:
- PMID:32296183
supported_by:
- reference_id: PMID:32296183
supporting_text: Apr 8. A reference map of the human binary protein
interactome.
- term:
id: GO:0090650
label: cellular response to oxygen-glucose deprivation
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >
This IEA annotation was transferred from orthologous genes via Ensembl Compara.
While autophagy is induced by metabolic stress including oxygen-glucose deprivation,
and DRAM1 is known to be p53-induced under stress conditions, this specific
annotation
lacks direct experimental support for human DRAM1.
action: KEEP_AS_NON_CORE
reason: >
The annotation is plausible given DRAM1's role as a stress-responsive autophagy
modulator that is induced by p53 activation. However, this represents a specific
stress context rather than core function. The evidence is transferred from
orthologs
rather than direct experimental evidence for human DRAM1.
additional_reference_ids:
- GO_REF:0000107
- term:
id: GO:0010506
label: regulation of autophagy
evidence_type: IDA
original_reference_id: PMID:19895784
review:
summary: >
CRITICAL ISSUE: PMID:19895784 (Park et al., 2009) is primarily about DRAM2/TMEM77,
not
DRAM1. The paper identifies DRAM2 as a DRAM-homologous protein and studies
its
lysosomal localization. While the paper mentions that co-expression of DRAM2
with
DRAM (DRAM1) induces cell death, the primary focus is on DRAM2. Nevertheless,
the
annotation itself (regulation of autophagy for DRAM1) is correct based on
other
literature; this reference is just poorly chosen.
action: ACCEPT
reason: >
The annotation (regulation of autophagy) is correct for DRAM1 based on extensive
literature evidence, even though this particular reference primarily characterizes
DRAM2 rather than DRAM1. The core function is well-supported by other studies
(PMID:16839881, PMID:17304243).
additional_reference_ids:
- PMID:16839881
- PMID:17304243
supported_by:
- reference_id: PMID:16839881
supporting_text: "Here we describe DRAM (damage-regulated autophagy modulator),
a p53 target gene encoding a lysosomal protein that induces macroautophagy"
- reference_id: PMID:19895784
supporting_text: Reduced expression of DRAM2/TMEM77 in tumor cells
interferes with cell death.
- reference_id: PMID:17304243
supporting_text: 2007 Feb 16. p73 regulates DRAM-independent autophagy
that does not contribute to programmed cell death.
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:19895784
review:
summary: >
This annotation citing cytoplasmic localization for DRAM1 based on PMID:19895784
is
problematic. First, this paper primarily studies DRAM2, not DRAM1. Second,
DRAM1 is
specifically a lysosomal membrane protein - while the lysosome is within the
cytoplasm,
annotating DRAM1 to "cytoplasm" is misleading as it is a membrane-bound protein
with
specific organellar localization.
action: REMOVE
reason: >
DRAM1 is a multi-pass transmembrane protein specifically localized to lysosomal
membranes, not a cytoplasmic protein. This annotation is overly broad and
misleading.
The reference (PMID:19895784) primarily characterizes DRAM2, not DRAM1. The
more
appropriate localization terms (lysosome, lysosomal membrane) are already
annotated.
additional_reference_ids:
- PMID:19895784
supported_by:
- reference_id: file:human/DRAM1/DRAM1-deep-research-falcon.md
supporting_text: "DRAM1 is a conserved, multi-pass lysosomal membrane protein
(six transmembrane segments) whose C-terminus faces the cytosol"
- reference_id: PMID:19895784
supporting_text: Reduced expression of DRAM2/TMEM77 in tumor cells
interferes with cell death.
- term:
id: GO:0005764
label: lysosome
evidence_type: IDA
original_reference_id: PMID:19895784
review:
summary: >
While the lysosomal localization of DRAM1 is correct and well-supported by
other
literature (PMID:16839881), this specific reference (PMID:19895784) primarily
characterizes DRAM2 rather than DRAM1. The annotation is valid but the reference
is suboptimal; PMID:16839881 would be a better primary reference.
action: ACCEPT
reason: >
Lysosomal localization is a core, well-documented feature of DRAM1 supported
by
multiple studies. While PMID:19895784 primarily studies DRAM2 and mentions
DRAM1
co-localization, better references exist (PMID:16839881). The IDA annotation
is
retained as the biological assertion is correct.
additional_reference_ids:
- PMID:16839881
supported_by:
- reference_id: PMID:16839881
supporting_text: "a p53 target gene encoding a lysosomal protein that induces
macroautophagy"
# New annotations suggested based on recent literature
- reference_id: PMID:19895784
supporting_text: Reduced expression of DRAM2/TMEM77 in tumor cells
interferes with cell death.
- term:
id: GO:0160177
label: positive regulation of autophagosome-lysosome fusion
evidence_type: IDA
original_reference_id: DOI:10.1038/s41467-025-60887-y
review:
summary: >
Recent mechanistic studies (Zhang et al., 2025 Nature Communications) demonstrate
that DRAM1 promotes autophagosome-lysosome fusion by stabilizing lysosomal
VAMP8.
DRAM1 binds VAMP8 and blocks CHIP-mediated ubiquitination at Lys68/72/75,
enabling
assembly of the STX17-SNAP29-VAMP8 SNARE complex required for autophagosome-lysosome
fusion.
action: NEW
reason: >
This annotation captures the specific mechanism by which DRAM1 regulates autophagy.
While GO:0010506 (regulation of autophagy) is already annotated, this more
specific
term accurately describes the molecular function revealed by recent research.
The
evidence is from a 2025 Nature Communications paper with detailed biochemical
characterization.
supported_by:
- reference_id: file:human/DRAM1/DRAM1-deep-research-falcon.md
supporting_text: "DRAM1 directly stabilizes VAMP8, enabling STX17-SNAP29-VAMP8
assembly to drive autolysosome formation"
- term:
id: GO:0000149
label: SNARE binding
evidence_type: IDA
original_reference_id: DOI:10.1038/s41467-025-60887-y
review:
summary: >
Zhang et al. (2025) demonstrated that DRAM1 directly binds VAMP8, a SNARE
protein
(R-SNARE/v-SNARE) on lysosomes. This interaction is essential for DRAM1's
function
in promoting autophagosome-lysosome fusion.
action: NEW
reason: >
This MF term captures the specific molecular interaction underlying DRAM1's
function.
VAMP8 is a well-characterized SNARE protein, and DRAM1 binding to it is mechanistically
important for autolysosome formation. This is more informative than generic
"protein binding".
supported_by:
- reference_id: file:human/DRAM1/DRAM1-deep-research-falcon.md
supporting_text: "DRAM1 binds and stabilizes lysosomal VAMP8 by blocking
CHIP-mediated ubiquitination (Lys68/72/75)"
- term:
id: GO:1904417
label: positive regulation of xenophagy
evidence_type: IMP
original_reference_id: DOI:10.3389/fcimb.2023.1331818
review:
summary: >
Studies in zebrafish show that dram1 overexpression enhances xenophagy-mediated
defense against Mycobacterium marinum infection, increasing LC3 recruitment
and
acidification of mycobacteria-containing compartments (Xie & Meijer, 2024).
action: NEW
reason: >
Xenophagy (selective autophagy of intracellular pathogens) is a specific biological
role for DRAM1 in host defense. While this evidence is from zebrafish, DRAM1
is
conserved and this function is likely relevant to the human protein as well,
particularly given the TLR-MYD88-NF-kB regulation pathway.
supported_by:
- reference_id: file:human/DRAM1/DRAM1-deep-research-falcon.md
supporting_text: "dram1 mRNA overexpression increased LC3 colocalization
with Mycobacterium marinum and reduced pathogen burden"
references:
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000043
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword
mapping
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular
Location vocabulary mapping
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation
data to orthologs using Ensembl Compara
findings: []
- id: PMID:16839881
title: "DRAM, a p53-induced modulator of autophagy, is critical for apoptosis"
findings:
- statement: DRAM1 is a p53 target gene encoding a lysosomal protein
supporting_text: "Here we describe DRAM (damage-regulated autophagy modulator),
a p53 target gene encoding a lysosomal protein that induces macroautophagy"
- statement: DRAM1 induces macroautophagy
supporting_text: "a p53 target gene encoding a lysosomal protein that induces
macroautophagy"
- statement: DRAM1 is essential for p53-mediated apoptosis
supporting_text: "while overexpression of DRAM alone causes minimal cell death,
DRAM is essential for p53-mediated apoptosis"
- id: PMID:17304243
title: "p73 regulates DRAM-independent autophagy that does not contribute to programmed
cell death"
findings:
- statement: p73 also regulates DRAM and autophagy
supporting_text: "TA-p73 also regulates DRAM and autophagy, with different
TA-p73 isoforms regulating DRAM and autophagy to varying extents"
- statement: p73 modulation of autophagy is DRAM-independent
supporting_text: "RNAi knockdown of DRAM, however, revealed that p73's modulation
of autophagy is DRAM-independent"
- id: PMID:19895784
title: Reduced expression of DRAM2/TMEM77 in tumor cells interferes with
cell death
findings:
- statement: DRAM2 co-localizes with DRAM1 in lysosomes
- statement: Co-expression of DRAM1 and DRAM2 induces cell death
- id: PMID:25416956
title: A proteome-scale map of the human interactome network
findings:
- statement: High-throughput Y2H study identifying protein-protein
interactions
- id: PMID:32296183
title: A reference map of the human binary protein interactome
findings:
- statement: HuRI systematic interactome map identifying DRAM1 interaction
partners
- id: file:human/DRAM1/DRAM1-deep-research-falcon.md
title: Deep research summary on DRAM1 function
findings:
- statement: DRAM1 promotes ER-lysosome membrane contacts via STIM1
supporting_text: "DRAM1 physically and functionally promotes ER-lysosome contacts
via STIM1, disrupting ER structure, triggering ER stress, and inducing ER-phagy"
- statement: DRAM1 stabilizes lysosomal VAMP8
supporting_text: "DRAM1 binds and stabilizes lysosomal VAMP8 by blocking CHIP-mediated
ubiquitination (Lys68/72/75)"
- statement: DRAM1 promotes STX17-SNAP29-VAMP8 SNARE complex assembly
supporting_text: "DRAM1 thereby promotes assembly of the STX17-SNAP29-VAMP8
SNARE complex, enhancing autophagosome-lysosome fusion"
- statement: DRAM1 has 6 transmembrane segments with cytosolic C-terminus
supporting_text: "DRAM1 is a conserved, multi-pass lysosomal membrane protein
(six transmembrane segments) whose C-terminus faces the cytosol"
- id: DOI:10.1038/s41467-025-60887-y
title: "DRAM1 promotes the stability of lysosomal VAMP8 to enhance autolysosome
formation and facilitates the extravasation"
findings:
- statement: DRAM1 binds and stabilizes lysosomal VAMP8
supporting_text: "DRAM1 binds and stabilizes lysosomal VAMP8 by blocking CHIP-mediated
ubiquitination (Lys68/72/75)"
- statement: DRAM1 promotes STX17-SNAP29-VAMP8 SNARE complex assembly
supporting_text: "DRAM1 directly stabilizes VAMP8, enabling STX17-SNAP29-VAMP8
assembly to drive autolysosome formation"
- id: DOI:10.3389/fcimb.2023.1331818
title: "Xenophagy receptors Optn and p62 and autophagy modulator Dram1 independently
promote the zebrafish host defense against Mycobacterium marinum"
findings:
- statement: dram1 promotes xenophagy in zebrafish
supporting_text: "dram1 mRNA overexpression increased LC3 colocalization with
Mycobacterium marinum and reduced pathogen burden"
core_functions:
- molecular_function:
id: GO:0000149
label: SNARE binding
description: >
DRAM1 binds VAMP8 (a lysosomal SNARE protein), stabilizing it and enabling
STX17-SNAP29-VAMP8 SNARE complex assembly for autophagosome-lysosome fusion.
locations:
- id: GO:0005765
label: lysosomal membrane
directly_involved_in:
- id: GO:0160177
label: positive regulation of autophagosome-lysosome fusion
- id: GO:0010506
label: regulation of autophagy
supported_by:
- reference_id: file:human/DRAM1/DRAM1-deep-research-falcon.md
supporting_text: "DRAM1 binds and stabilizes lysosomal VAMP8 by blocking CHIP-mediated
ubiquitination (Lys68/72/75)"
proposed_new_terms: []
suggested_questions:
- question: What is the structure of DRAM1 and how does it interact with
VAMP8?
- question: Does DRAM1 have any enzymatic activity or is it purely an
adapter/scaffold?
- question: How is DRAM1 trafficking from Golgi to lysosomes regulated beyond
AP-4?
- question: What determines whether DRAM1 promotes protective autophagy vs
apoptosis?
suggested_experiments:
- description: Structural studies (cryo-EM or crystallography) of DRAM1-VAMP8
complex
hypothesis: Determine the molecular basis of DRAM1-VAMP8 interaction
- description: Functional studies of DRAM1 in human xenophagy (bacterial
infection models)
hypothesis: Confirm xenophagy function demonstrated in zebrafish also
applies to human DRAM1
- description: Proximity labeling (BioID/APEX) to identify full DRAM1
interactome at lysosomes
hypothesis: Identify additional DRAM1 interaction partners at lysosomal
membranes
- description: CRISPR screens to identify synthetic lethal interactions with
DRAM1 in autophagy-dependent cancer
hypothesis: Identify therapeutic targets that synergize with DRAM1 loss